160 studies found for:    Open Studies | "Pharyngeal Neoplasms"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Pharyngeal Neoplasms" (160 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy
Conditions: Pharyngeal Neoplasms;   Laryngeal Neoplasms;   Carcinoma
Interventions: Device: prothesis voice;   Procedure: total laryngectomy
2 Not yet recruiting Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy
Conditions: Dysphagia;   Oral Pharyngeal Cancer
Intervention: Device: Iowa Oral Performance Instrument
3 Unknown  Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Conditions: Cancer of the Pharynx;   Cancer of the Larynx;   Cancer of the Neck;   Paranasal Sinus Neoplasms;   Cancer of the Head
Intervention: Drug: erlotinib + celecoxib
4 Not yet recruiting Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122)
Condition: Nasopharyngeal Neoplasms
Interventions: Biological: pembrolizumab;   Drug: capecitabine;   Drug: gemcitabine;   Drug: docetaxel
5 Not yet recruiting Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin 2;   Drug: Docetaxel;   Drug: Cisplatin 1;   Radiation: Intensity-modulated radiotherapy
6 Recruiting Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin;   Radiation: Intensity-modulated radiotherapy
7 Not yet recruiting Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: PDR001;   Drug: Investigator choice of chemotherapy
8 Recruiting Nasopharyngeal Carcinoma Post IMRT
Condition: Nasopharyngeal Carcinoma
9 Recruiting A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Recombinant Human Endostatin Injection (Endostar);   Drug: Fluorouracil (5-Fu);   Drug: Nedaplatin
10 Not yet recruiting Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China
Condition: Nasopharyngeal Cancinoma (NPC)
11 Recruiting NBI to Detect Post-RT Mucosal Residual NPC
Condition: Nasopharyngeal Carcinoma
Intervention: Device: Laryngoscope with NBI system
12 Not yet recruiting Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Current Smoker;   Head and Neck Squamous Cell Carcinoma;   Hypopharyngeal Squamous Cell Carcinoma;   Laryngeal Squamous Cell Carcinoma;   Nasopharyngeal Carcinoma;   Oral Cavity Squamous Cell Carcinoma;   Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Bupropion Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Nicotine Replacement;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Varenicline
13 Recruiting Multicentre, Randomized, Open-Label, Phase III Clinical Trial for Advanced Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Cancer
Interventions: Biological: autologous EBV specific Cytotoxic T Lymphocytes;   Drug: combination IV gemcitabine and IV carboplatin (AUC2)
14 Recruiting Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
Conditions: Nasopharyngeal Carcinoma;   Malnutrition
Intervention: Drug: cisplatin and docetaxel
15 Recruiting Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Radiation: CIRT arm
16 Recruiting Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: raltitrexed-cisplatin;   Radiation: Intensity-modulated radiotherapy (IMRT)
17 Recruiting HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Conditions: Human Papilloma Virus Infection Type 11;   Human Papilloma Virus Infection Type 16;   Human Papilloma Virus Infection Type 18;   Human Papilloma Virus Infection Type 6;   Cervical Cancer;   Genital Warts;   Oropharyngeal Cancer
Intervention: Behavioral: Simple Reminder
18 Recruiting Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx
Condition: Squamous Cell Carcinoma of the Oropharynx
Intervention: Procedure: Ability to swallow, speak and quality of life
19 Recruiting Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
Conditions: Head and Neck Squamous Cell Carcinoma;   Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Recurrent Nasopharynx Carcinoma;   Recurrent Salivary Gland Carcinoma;   Salivary Gland Carcinoma;   Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary;   Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage III Nasopharyngeal Carcinoma;   Stage IV Nasopharyngeal Carcinoma;   Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Drug: Vorinostat
20 Recruiting The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Celecoxib;   Drug: Nedaplatin;   Radiation: Concurrent Radiotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years